ad image

Genetech

1 / 1
Genentech

Genentech Launches Oncology Clinical Trial Diversity Alliance

Genentech

PR-M06-21-031Jun 24, 2021
Genentech

Genentech’s Phase III EMPACTA Study Showed Actemra Reduced the Likelihood of Needing Mechanical Ventilation in Hospitalized Patients With COVID-19 Associated Pneumonia

Genentech

PA1285Sep 18, 2020
Genentech
FDA

FDA Accepts Application for Xolair Prefilled Syringe for Self-Administration Across All Indications

Genentech

PR-M08-20-NI-32Aug 19, 2020
Genentech’s Xofluza Flu Treatment Effective in Children
Influenza

Genentech’s Xofluza Flu Treatment Effective in Children

Emilie Branch

Pharma's Almanac

PAO-M07-19-NI-019Jul 22, 2019
Genetech’s Antibody–Drug Conjugate Receives FDA Approval
FDA Approval

Genetech’s Antibody–Drug Conjugate Receives FDA Approval

Pharma's Almanac

PAO-M06-19-NI-010Jun 20, 2019
U.S. Food & Drug Administration
FDA Approval

FDA Approves Venetoclax for CLL and SLL

U.S. Food & Drug Administration

PR-M05-19-NI-057May 20, 2019
Genentech
FDA Approval

Genentech Announces FDA Approval for Venclexta Plus Gazyva for People With Previously Untreated Chronic Lymphocytic Leukemia

Genentech

PR-M05-19-NI-050May 17, 2019
Genentech
Clinical Data

New OCREVUS (Ocrelizumab) Data at AAN Demonstrate Significant Reductions in Disease Activity and Disability Progression in Relapsing Multiple Sclerosis

Genentech

PR-M04-18-NI-88Apr 25, 2018
1 / 1